A Predictive Immunological Signature Associated with Pathological Response in Breast Cancer Treated with Neoadjuvant Chemotherapy.

Biomedicines · 2026 · PMC13023440 · PMID 41898309

Europe PMC DOI

hedged sentence

0.0069

closest p · 0.1× alpha

0.0069

boldest claim

The sentences

nominally significantp = 0.0069actually significant

Specifically, tumors from chemosensitive patients showed nominally significant enrichment in natural killer (NK) cells ( p = 0.0069, BH adj. p = 0.1596), CD4+ Th1 T cells ( p = 0.0089, BH adj. p = 0.1596), and CD4+ non-regulatory T cells ( p = 0.0290, BH adj. p = 0.3423).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.